BCPC Stock Analysis: Buy, Sell, or Hold?

BCPC - Balchem Corporation

CHEMICALS & ALLIED PRODUCTS
$24.86
0.05 (0.20%) β–²
HOLD
MODERATE Confidence
Protect Your BCPC Gains
Last Updated: January 30, 2026
Earnings: Feb 20, 2026 18d

Get Alerted When BCPC Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ“Š HOLD: BCPC shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$111.40
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$69.17
64.1% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.6x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: BCPC is currently trading at $24.86, which is considered slightly low relative to its 30-day fair value range of $2.11 to $118.70. From a valuation perspective, the stock is trading at a discount (Forward PE: 4.5) compared to its historical average (14.6). Remarkably, the market is currently pricing in an annual earnings decline of 32.6% over the next few years. This pessimistic expectation contrasts with the company's recent 20.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.

Technical Outlook: Technically, BCPC is in a strong downtrend. The price is currently testing key support at $24.78. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: BCPC has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $191.00 (+668.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Fair Price Range $2.11 - $118.70
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.1%

Protect Your Profits

Holding BCPC? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 668.3% below Wall St target ($191.00)

Fair Price Analysis

30-Day Fair Range $2.11 - $118.70
Current vs Fair Value SLIGHTLY LOW

Support & Resistance Levels

Support Level $24.78
Resistance Level $25.30
Current Trend Strong Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 4.46
Wall Street Target $191.00 (+668.3%)
Revenue Growth (YoY) 11.5%
Earnings Growth (YoY) 20.4%
Profit Margin 14.7%
Valuation Discount vs History -32.6% cheaper
PE vs Historical 4.5 vs 14.6 CHEAP
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -32.6% (market-implied from PE analysis)
1-Year Target $22.37 (-10%)
2-Year Target $20.14 (-19%)
3-Year Target $18.12 (-27%)
3-Yr Target (if PE normalizes) (PE: 4β†’15) $59.31 (+139%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: 9.0%) $161.14 (+548%)
Base: (SPY PE: 4.5, Growth: 9.0%) $32.24 (+30%)
Bear: (PE: 3.8, Growth: 9.0%) $27.40 (+10%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 36.79 | Current EPS (TTM): $4.57
Bull Case $225.54 (+807%)
Analyst growth 21.9%, PE expands to 40.5
Base Case $205.04 (+725%)
Market implied 21.9%, PE stable at 36.8
Bear Case $114.34 (360%)
Severe decline -20.0%, PE contracts to 31.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 4.5 to 14.6
Stabilization Target: $81.36 (+227.3%)
PE Expansion Potential: +227.3%
Last updated: January 31, 2026 11:18 PM ET
Data refreshes hourly during market hours. Next update: 12:18 AM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Specialty Chemicals Stocks

Top-rated stocks in Specialty Chemicals by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LIN
Linde plc Ordinary Shares
BUY
28 analysts
$505 63 BUY
SHW
Sherwin-Williams Co
BUY
28 analysts
$386 61 BUY
DD
Dupont De Nemours Inc
STRONG BUY
20 analysts
$49 65 BUY
APD
Air Products and Chemica…
BUY
24 analysts
$294 66 BUY
IFF
International Flavors & …
STRONG BUY
22 analysts
$82 60 HOLD

Advanced BCPC Option Strategies

Professional options setups generated by AI based on today's BCPC price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for BCPC

BCPC Technical Chart BCPC Price Prediction BCPC Earnings Date BCPC Investment Advisor BCPC Fair Price Analyzer BCPC Options Advisor BCPC Options Chain BCPC Options Analysis BCPC Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals